Skip to content

Amsterdam UMC makes use of cookies

Some of these cookies are ‘strictly necessary’, or essential for technical reasons. Others are used to improve the website. We also use cookies to enable the viewing of video material and animations. By opting to “accept cookies”, you agree to the use of all of the cookies described in our cookie policy. Should you choose to “refuse cookies”, only ‘strictly necessary’ and analytics cookies will be placed on your device. You can change your preferences at any time via the cookie policy.

About Amsterdam UMC

Research Imaging Core Center

  • Women with menstrual disorders to receive earlier treatment thanks to major FEMCURE project
    Women with menstrual disorders to receive earlier treatment thanks to major FEMCURE project One in three women experiences menstrual problems due to conditions such as endometriosis, fibroids, or scarring in the uterus. Nevertheless, it often takes 8 to 11 years before they receive a clear diagnosis, and targeted treatments are lacking. The FEMCURE project, led by Professor of Gynaecology Judith Huirne, aims to drastically shorten the time to effective treatment. Researchers will develop self-tests that allow women to assess their symptoms at home. In addition, methods will be devised to help general practitioners and gynaecologists recognize these conditions more quickly. The researchers are also developing targeted therapies, ensuring that each woman receives the treatment most effective for her.
  • Temporary benefit for immune system in early HIV treatment, but dysregulation returns
    Temporary benefit for immune system in early HIV treatment, but dysregulation returns Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at Amsterdam UMC investigated whether this dysregulation can be prevented by starting HIV medication immediately after infection – i.e. within a few days. They saw that six months after this early treatment, the immune system did indeed work as in people without HIV. But in the longer term, the immune system was disrupted again. This is shown by research by Amsterdam UMC, published in the journal EBioMedicine.
  • Transgender women do not have an increased risk of heart attack and stroke
    Transgender women do not have an increased risk of heart attack and stroke Contrary to previous research, transgender women who use the hormone oestradiol for their transition do not have an increased risk of heart attack and stroke compared to men in the general Dutch population. This is shown by a large-scale study from Amsterdam UMC, with data from more than 4,000 transgender individuals, published today in the European Heart Journal. The researchers suspect that the hormone treatment transgender women receive has a protective effect on the heart and blood vessels.

Amsterdam UMC is hiring

We are always on the lookout for talented and passionate people to join our growing team. You will have the opportunity to develop any aspects you are interested in.

See all our vacancies (in Dutch):

Job opportunities
Amsterdam UMC is hiring